4453 Total Publications
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., & Riddle, W. R.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 9; pp. 1564-9;
doi:10.2967/jnumed.112.116137
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50;
doi:10.1038/nature12415
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94;
doi:10.1016/j.nicl.2013.07.005
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443;
doi:10.1371/journal.pone.0085443
STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation.
Jorge Cardoso, M., Leung, K., Modat, M., Keihaninejad, S., Cash, D., Barnes, J., … Ourselin, S.
2013; Journal Medical Image Analysis; vol. 17; no. 6; pp. 671-84;
doi:10.1016/j.media.2013.02.006
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50;
doi:10.1038/nature12415
Clinical and multimodal biomarker correlates of ADNI neuropathological findings.
Toledo, J. B., Cairns, N. J., Da, X., Chen, K., Carter, D., Fleisher, A., … Trojanowski, J. Q.
2013; Journal Acta Neuropathologica Communications; vol. 1; no. 1; pp. 65;
doi:10.1186/2051-5960-1-65